Tactile Systems Technology, Inc. (TCMD): Enterprise Value to EBITDA Ratio
Tactile Systems Technology (TCMD) optimizes component production through external contractors and delegates the delivery of consumables to logistics operators. The market capitalization trend, recorded at 13.18, complements a non-M&A growth strategy based on hiring new sales agents. The lymphedema treatment business relies on the US domestic market, which minimizes geopolitical threats despite potential price increases resulting from trade disputes with China.
Comprehensive metric breakdowns and analytics for tactilemedical.com (TCMD)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Tactile Systems Technology|TCMD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Tactile Medical|TCMD - Company Total Debt|Debts to Book Capitalization Tactile Medical|TCMD - Long-Term Debt|Company Short-Term Debts Tactile Medical|Quick Ratio tactilemedical.com
- financial results and valuation multiples details:
TCMD - Net Financial Result|Projected Future Earnings Tactile Systems Technology|TCMD - Price to Earnings Ratio|Forward P/E Multiple Tactile Medical|TCMD - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tactile Medical|TCMD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Tactile Medical|TCMD - Earnings per share for the trailing year|Quarterly EPS earnings growth tactilemedical.com|TCMD - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Tactile Systems Technology
Analysis of all company metrics:Tactile Systems Technology Inc. TCMD
Tactile Systems Technology (TCMD) dominates the home lymphedema therapy segment, necessitating a precise business valuation analysis. This multiple compares the company's enterprise value (EV), including debt, to its operating profit before depreciation and amortization. By analyzing the EV/EBITDA chart for Tactile Systems Technology (TCMD), an investor assesses the efficiency of capitalizing market share into actual cash flow. A stable trend confirms the fair value of assets relative to their ability to generate profit.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA SANUWAVE Health Inc|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR) - EV/EBITDA Multiple|AVITA Medical Inc. (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM (BioSig Technologies, Inc.) - Enterprise Value to EBITDA Ratio|CUTR: Enterprise Value to Operating Income Before Depreciation Ratio|KNW (Know Labs) - EV/EBITDA Multiple|EV/EBITDA Multiple Inari Medical Inc|EV/EBITDA Multiple NVRO|Enterprise Value to EBITDA Ratio reshapelifesciences.com RSLS|Silk Road Medical, Inc - Enterprise Value to EBITDA Ratio
